Rekord LOINC: 88999-8
Dostępne tłumaczenie polskie ACTIVE
Tłumaczenie polskie
Komponent
Właściwość
Aspekt czasowy
System
Typ skali
Klasa
Krótka nazwa
Długa nazwa wspólna
Definicja i opis
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
88999-8
FHIR
|
| Long Common Name: | Omega-3 (EPA+DHA) index risk in Serum or Plasma |
| Short Name: | Omega-3 index risk SFr SerPl |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
PL
Tłumaczenie polskie
Eikozapentaenian+Dokozaheksanian/wskaźnik ryzyka (sercowo-naczyniowego) na podstawie kwasów tłuszczowych C14-C24
:
ocena
:
punkt w czasie
:
surowica lub osocze
:
uporządkowany
:
-
EN
Oryginalna wersja angielska
Eicosapentaenoate+docosahexaenoate/Fatty acids.C14-C24 index risk
:
Imp
:
Pt
:
Ser/Plas
:
Ord
:
-
Klasyfikacja
| Class: |
PLbadania biochemiczne - testy bez obciążenia
ENCHEM
|
| Consumer Name: | - |
| Order/Observation: | Both |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | - |
| UCUM Units: | - |
| Version Last Changed: | 2.73 |
Definicja i opis
EN
The omega-3 index, defined as eicosapentaenoate (EPA)+ docosahexaenoate (DHA)/Fatty acids.C14-C24, is a clinically useful measurement for evaluating blood levels of EPA and DHA. There are many health benefits from maintaining a good level of omega-3 fatty acids including reduced inflammation, risk of heart disease, cancer, arthritis, and many more. Deficiency in omega-3 fatty acids can result in fatigue, poor memory, dry skin, heart problems, mood swings, and poor circulation.[https://www.umm.edu/health/medical/altmed/supplement/omega3-fatty-acids] There have been a number of clinical trials to determine the effect of omega-3 supplementation based on a 1g/day dose of EPA, which successfully increased the total omega-3 level to >5% for 84% of the study participants. The remaining 16% had levels below 5%, which is the threshold at which significant reduction in sudden coronary death reduction is evident. The variability in the blood levels of omega-3 in patients who received the same supplemental dose of omega-3 has been attributed to genetic differences in fatty acid metabolism, body weight, baseline omega-3 level, age, gender, and physical activity.[PMID: 25285179] This test measures the level of omega-3 as a percent of total fatty acids, and the result of that index is associated with a high, moderate, or low risk of cardiovascular disease.
Powiązane nazwy
Eikozapentaenian i Dokozaheksanian